(Q36166433)

12 August 2017

1 reference

title

Cognitive performance in patients with Alzheimer's disease receiving cholinesterase inhibitors for up to 5 years (English)

1 reference

12 August 2017

0 references

Bullock R

1

1 reference

12 August 2017

Dengiz A

series ordinal

2

1 reference

12 August 2017

publication date

1 July 2005

1 reference

International Journal of Clinical Practice

12 August 2017

published in

1 reference

12 August 2017

volume

59

1 reference

12 August 2017

issue

7

1 reference

12 August 2017

page(s)

817-822

1 reference

Neuropsychiatric aspects of Alzheimer's disease: the cholinergic hypothesis revisited

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2005.00562.X

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2005.00562.X

Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2005.00562.X

A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2005.00562.X

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2005.00562.X

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2005.00562.X

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2005.00562.X

10.1111/J.1368-5031.2005.00562.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference